WishBone Medical entered into an agreement with Vizient, a member-driven healthcare performance improvement company, to provide anatomically appropriate orthopedic solutions for arms, legs, spine, elbows, wrists and clavicles to U.S. surgeons caring for children.
Vizient’s membership base comprises more than 50% of the nation’s acute care providers, including 95% of the nation’s academic medical centers and more than 20% of ambulatory providers.
Through Vizient’s membership base, WishBone’s “Just-In-Time” supply will allow healthcare facilities to benefit from immediate availability and shipment of product at contracted prices, as needed.
Nick Deeter, WishBone Founder and CEO, said, “In the year 2020, there is still a huge technology deficit in the O.R. with 95% of children receiving adult implants not cleared by the FDA for pediatric use. In some instances, these off-label applications can cause more harm than good. WishBone is thrilled about another game-changing opportunity to create greater access to solutions that are truly designed around the unmet needs of kids.”
WishBone Medical entered into an agreement with Vizient, a member-driven healthcare performance improvement company, to provide anatomically appropriate orthopedic solutions for arms, legs, spine, elbows, wrists and clavicles to U.S. surgeons caring for children.
Vizient’s membership base comprises more than 50% of the nation’s acute care...
WishBone Medical entered into an agreement with Vizient, a member-driven healthcare performance improvement company, to provide anatomically appropriate orthopedic solutions for arms, legs, spine, elbows, wrists and clavicles to U.S. surgeons caring for children.
Vizient’s membership base comprises more than 50% of the nation’s acute care providers, including 95% of the nation’s academic medical centers and more than 20% of ambulatory providers.
Through Vizient’s membership base, WishBone’s “Just-In-Time” supply will allow healthcare facilities to benefit from immediate availability and shipment of product at contracted prices, as needed.
Nick Deeter, WishBone Founder and CEO, said, “In the year 2020, there is still a huge technology deficit in the O.R. with 95% of children receiving adult implants not cleared by the FDA for pediatric use. In some instances, these off-label applications can cause more harm than good. WishBone is thrilled about another game-changing opportunity to create greater access to solutions that are truly designed around the unmet needs of kids.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
